Open tender · Germany · Cn Standard
Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Urapidil (ATC-Code: C02CA06).
AOK Niedersachsen. Die Gesundheitskasse.
The work
Conclusion of a non-exclusive discount contract for the drug Urapidil (ATC-Code: C02CA06) from 01.02.2026 to 31.01.2028.
- Contract must be for the drug Urapidil (ATC-Code: C02CA06).
- Contract duration is from 01.02.2026 to 31.01.2028.
- Contracts are non-exclusive and follow an 'open-house-Modell'.
Key facts
- Contract period
- 24 months
- Evaluation
- Not a public procurement in the sense of Directive 2014/24/EU.
What it takes to qualify
Worth a closer look
- The tender is not a public procurement in the sense of Directive 2014/24/EU, but a publication for transparency in the Supplement to the Official Journal of the European Union.
- The exact input deadlines for later contract conclusions are to be specified in the contract documents.
Experience
- At least 1 similar work — Experience as a pharmaceutical entrepreneur for the drug Urapidil (ATC-Code: C02CA06).
- Experience as a pharmaceutical entrepreneur for the drug Urapidil (ATC-Code: C02CA06).
Certifications and registrations
Pharmazeutischer Unternehmer i. S. d. § 4 Abs. 18 AMGMust be a pharmaceutical entrepreneur as defined by § 4 Abs. 18 AMG.
Pharmazeutischer Unternehmer i. S. d. § 4 Abs. 18 AMG§ 130a Abs. 8 Satz 1 SGB V requires contracts only with pharmaceutical entrepreneurs as defined by § 4 Abs. 18 AMG.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- VertragsunterlagenContract documents must be submitted to AOK Niedersachsen.